Antibiotic resistance among hospital-acquired infections is much greater than prior CDC estimates

FDA 'reboot' of antibiotic development rules falls short

2013-08-01

(Press-News.org) LOS ANGELES – (August 1, 2013) – The rise of antibiotic resistance among hospital-acquired infections is greater than the Centers for Disease Control and Prevention (CDC) found in its 2008 analysis, according to an ahead-of-print article in the journal, Antimicrobial Agents and Chemotherapy.

The article also finds that the Food and Drug Administration's (FDA) promise to "reboot" antibiotic development rules a year ago to combat the rise in resistance has fallen short.

The commentary, whose authors include Brad Spellberg, MD, a Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) infectious disease specialist, analyzed privately gathered data and concluded antibiotic resistance among hospital-acquired infections is "at crisis levels." The FDA's "reboot" pledge to encourage the development of new antibiotics to battle this resistance "cannot come too soon" but "will not be enough," the authors conclude.

"With antibiotic-resistant microbes infecting more than 2 million Americans every year and killing more than 100,000 annually, we must act to find new weapons in the global battle against deadly Superbugs," said Dr. Spellberg, M.D., who authored "Rising Plague," a book on antibiotic resistance. "Our analysis found the rise in antibiotic resistance among three common forms of hospital-acquired infections is much greater than previously reported by the CDC based on older data, leading us to conclude that more than an FDA 'reboot' is needed. To encourage antibiotic development, the pharmaceutical industry must see that there is a path for a return on its investment in antibiotic development."

The authors found "very positive aspects" in the FDA's most recent guidance for antibacterial therapies for patients with unmet medical needs. But they said the FDA's approach to the development of antibacterials in traditional indications, such as pneumonia and urinary tract infections, "has been mixed."

Their findings on the rise on antibiotic resistance among hospital-acquired infections include:

The resistance for acinetobacter (A. baumannii) to carbapenems is more than 50%. The CDC found it to be 11%. Carbapenems are among the last available antibiotics. If they don't work, only one or two other drugs are left to battle these infections. Neither is very effective, and one is highly toxic. The resistance among E. coli to third generation cephalosporins (a class of antibiotics) was 8-11%. The CDC found it to be 5%. The resistance to klebsiella (K. pneumonia) to third generation cephalosporins was 20-27%. The CDC found it to be 15%. Resistance to carbapenems among these isolates is now between 7 and 11%. Carbapenems are already obsolete for a common Intensive Care Unit infection, Acinetobacter baumannii. "This holds true for both intensive care and non-intensive care patients and for urinary and non-urinary infections," the commentary says.

"None of the antibiotics under development today can address all of these antibiotic-resistant infections," said Dr. Spellberg. "A complete overhaul of the approaches to resistance, disease and prevention could change the continuing upward trajectory of antibiotic resistant infections. To do anything less invites a bleak post-antibiotic future, in which infectious diseases once again reign supreme."

### The commentary will appear in an upcoming issue of Antimicrobial Agents and Chemotherapy. The other authors are David M. Shlaes, MD, PhD; Dan Sahm, PhD, and Carol Opiela.

About LA BioMed

Founded in 1952, LA BioMed is one of the country's leading nonprofit independent biomedical research institutes. It has approximately 100 principal researchers conducting studies into improved treatments and cures for cancer, inherited diseases, infectious diseases, illnesses caused by environmental factors and more. It also educates young scientists and provides community services, including prenatal counseling and childhood nutrition programs. LA BioMed is academically affiliated with the David Geffen School of Medicine at UCLA and located on the campus of Harbor-UCLA Medical Center. For more information, please visit http://www.LABioMed.org.

ELSE PRESS RELEASES FROM THIS DATE:

Vanderbilt studies outline new model for staph bone infections

2013-08-01

Osteomyelitis, a debilitating bone infection most frequently caused by Staphylococcus aureus ("staph") bacteria, is particularly challenging to treat. Now, Vanderbilt microbiologist Eric Skaar, Ph.D., MPH, and colleagues have identified a staph-killing compound that may be an effective treatment for osteomyelitis, and they have developed a new mouse model that will be useful for testing this compound and for generating additional therapeutic strategies. James Cassat, M.D., Ph.D., a fellow in Pediatric Infectious Diseases who is interested in improving treatments for ...

Catching cancer early by chasing it

2013-08-01

WASHINGTON D.C. August 1, 2013 -- Reaching a clinic in time to receive an early diagnosis for cancer -- when the disease is most treatable -- is a global problem. And now a team of Chinese researchers proposes a global solution: have a user-friendly diagnostic device travel to the patient, anywhere in the world. As described in the journal Biomicrofluidics, which is produced by AIP Publishing, a team led by Gang Li, Ph.D., from Shanghai Institute of Microsystem and Information Technology at the Chinese Academy of Sciences, is developing a portable device for point-of-care ...

A roadblock to personalized cancer care?

2013-08-01

ANN ARBOR, Mich. — There's a major roadblock to creating personalized cancer care. Doctors need a way to target treatments to patients most likely to benefit and avoid treating those who will not. Tumor biomarker tests can help do this. The problem, according to a new commentary paper, is that, unlike drugs or other therapies, cancer biomarker tests are undervalued by doctors and patients. The authors say that inconsistent regulatory rules, inadequate payment and underfunded tumor biomarker research has left us in a vicious cycle that prevents development and testing ...

When prescribing antibiotics, doctors most often choose strongest types of drugs

2013-08-01

(SALT LAKE CITY)—When U.S. physicians prescribe antibiotics, more than 60 percent of the time they choose some of the strongest types of antibiotics, referred to as "broad spectrum," which are capable of killing multiple kinds of bacteria, University of Utah researchers show in a new study. Unfortunately, in more than 25 percent of such prescriptions are useless because the infection stems from a virus, which cannot be treated with antibiotics. This overuse of antibiotics has a number of downsides, including that these types of drugs kill more of the "good" bacteria ...

Existing cropland could feed 4 billion more

2013-08-01

The world's croplands could feed 4 billion more people than they do now just by shifting from producing animal feed and biofuels to producing exclusively food for human consumption, according to new research from the Institute on the Environment at the University of Minnesota. Even a smaller, partial shift from crop-intensive livestock such as feedlot beef to food animals such as chicken or pork could increase agricultural efficiency and provide food for millions, the study says. "We essentially have uncovered an astoundingly abundant supply of food for a hungry world, ...

Light that moves and molds gels

2013-08-01

PITTSBURGH—Some animals—like the octopus and cuttlefish—transform their shape based on environment, fending off attackers or threats in the wild. For decades, researchers have worked toward mimicking similar biological responses in non-living organisms, as it would have significant implications in the medical arena. Now, researchers at the University of Pittsburgh have demonstrated such a biomimetic response using hydrogels—a material that constitutes most contact lenses and microfluidic or fluid-controlled technologies. Their study, published in Advanced Functional ...

When it comes to skin cancer, pictures are worth 1,000 words

2013-08-01

WATERLOO, Ont. (Thursday, August 1, 2013) – Seeing pictures of skin cancer motivates people to regularly check their own moles, according to a new research paper from the School of Public Health and Health Systems at the University of Waterloo. The paper, published in the Journal of the American Academy of Dermatology, found that visual images of skin cancer are most effective in prompting skin self-examinations. "Visual images capture our attention and are persuasive. They also help us to learn and remember," said Professor Laurie Hoffman-Goetz, of the Faculty of Applied ...

Removing a protein enhances defense against bacteria in CGD mice

2013-08-01

Deletion of a protein in white blood cells improves their ability to fight the bacteria staphylococcus aureus and possibly other infections in mice with chronic granulomatous disease (CGD), according to a National Institutes of Health study. CGD, a genetic disorder also found in people, is marked by recurrent, life-threatening infections. The study's findings appear online in The Journal of Clinical Investigation. A team of researchers from NIH's National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) compared three groups: CGD-afflicted mice with the ...

Anemia linked to increased risk of dementia

2013-08-01

MINNEAPOLIS – Anemia, or low levels of red blood cells, may increase the risk of dementia, according to a study published in the July 31, 2013, online issue of Neurology®, the medical journal of the American Academy of Neurology. "Anemia is common in the elderly and occurs in up to 23 percent of adults ages 65 and older," said study author Kristine Yaffe, MD, with the University of California – San Francisco and a member of the American Academy of Neurology. "The condition has also been linked in studies to an increased risk of early death." For the study, 2,552 older ...

Citizen scientists rival experts in analyzing land-cover data

2013-08-01

Over the past 5 years, IIASA researchers on the Geo-Wiki project have been leading a team of citizen scientists who examine satellite data to categorize land cover or identify places where people live and farm. These data have led to several publications published in peer-reviewed journals. "One question we always get is whether the analysis from laypeople is as good as that from experts. Can we rely on non-experts to provide accurate data analysis?" says IIASA researcher Linda See, who led the study published in the journal PLOS ONE. The researchers compared 53,000 ...

nTIDE March 2025 Jobs Report: Employment rate for people with disabilities holds steady at new plateau, despite February dip

While most Americans strongly support civics education in schools, partisan divide on DEI policies and free speech on college campuses remains

Revolutionizing surface science: Visualization of local dielectric properties of surfaces

[Press-News.org] Antibiotic resistance among hospital-acquired infections is much greater than prior CDC estimates
FDA 'reboot' of antibiotic development rules falls short

Antibiotic resistance among hospital-acquired infections is much greater than prior CDC estimates

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: